Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Turnstone Biologics Corp. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +7 vs. Q1 2024
- Shares held
- 12.7M
- −647.7K (−4.9%) vs. Q1 2024
- Total value
- $33.3M
- −$1.70M (−4.9%) vs. Q1 2024
- New holders
- 16
- 11 more added
- Sold out
- 9
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 23 | $3.03M |
| Q1 2025 | 23 | $4.26M |
| Q4 2024 | 28 | $5.51M |
| Q3 2024 | 24 | $6.37M |
| Q2 2024 | 47 | $33.3M |
| Q1 2024 | 40 | $35.0M |
| Q4 2023 | 36 | $33.1M |
| Q3 2023 | 35 | $48.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Turnstone Biologics Corp.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 11 | $0 | 0.00% | −340−96.9% | Reduced |
| CWM, LLC | 49 | $0 | 0.00% | +49 | New |
| Nisa Investment Advisors, LLC | 54 | $141 | 0.00% | +24+80.0% | Added |
| New York State Common Retirement Fund | 125 | $328 | 0.00% | −18,717−99.3% | Reduced |
| Macquarie Group Ltd | 789 | $2.07K | 0.00% | +789 | New |
| Rhumbline Advisers | 860 | $2.25K | 0.00% | −8,249−90.6% | Reduced |
| Nordwand Advisors, LLC | 1,500 | $3.93K | 0.00% | +1,500 | New |
| UBS Group AG | 1,551 | $4.06K | 0.00% | −17,506−91.9% | Reduced |
| Russell Investments Group, Ltd. | 2,445 | $6.41K | 0.00% | +2,445 | New |
| Catalyst Funds Management Pty Ltd | 3,900 | $10.2K | 0.00% | +3,900 | New |
| JPMorgan Chase & Co | 6,841 | $17.9K | 0.00% | +671+10.9% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $21.3K | 0.00% | +8,135 | New |
| Tower Research Capital LLC (TRC) | 10,502 | $27.5K | 0.00% | +7,093+208.1% | Added |
| SEI Investments Co | 11,882 | $31.1K | 0.00% | +11,882 | New |
| O'Shaughnessy Asset Management, LLC | 13,737 | $36.0K | 0.00% | +13,737 | New |
| Virtu Financial LLC | 13,954 | $37.0K | 0.00% | +13,954 | New |
| Squarepoint Ops LLC | 15,018 | $39.3K | 0.00% | +15,018 | New |
| Morgan Stanley | 18,759 | $49.1K | 0.00% | −4,835−20.5% | Reduced |
| Qube Research & Technologies Ltd | 19,025 | $49.8K | 0.00% | +19,025 | New |
| Citigroup Inc | 24,825 | $65.0K | 0.00% | +21,886+744.7% | Added |
| Bridgeway Capital Management, LLC | 24,900 | $65.2K | 0.00% | −35,000−58.4% | Reduced |
| Centiva Capital, LP | 25,225 | $66.1K | 0.00% | +25,225 | New |
| Y-Intercept (Hong Kong) Ltd | 35,771 | $93.7K | 0.01% | +35,771 | New |
| Jane Street Group, LLC | 36,609 | $95.9K | 0.00% | +36,609 | New |
| BlackRock Inc. | 41,344 | $108.3K | 0.00% | −622,060−93.8% | Reduced |
| Kathleen S. Wright Associates Inc. | 42,553 | $111.5K | 0.05% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 51,293 | $134.4K | 0.00% | +27,922+119.5% | Added |
| Balyasny Asset Management LLC | 53,682 | $140.6K | 0.00% | +20,936+63.9% | Added |
| Geode Capital Management, LLC | 71,952 | $188.6K | 0.00% | −166,132−69.8% | Reduced |
| Goldman Sachs Group Inc | 73,288 | $192.0K | 0.00% | +73,288 | New |
| Northern Trust Corp | 94,234 | $246.9K | 0.00% | −5,241−5.3% | Reduced |
| Barclays PLC | 115,978 | $303.9K | 0.00% | −5,403−4.5% | Reduced |
| Millennium Management LLC | 125,857 | $329.7K | 0.00% | +125,857 | New |
| FIL Ltd | 192,657 | $504.8K | 0.00% | 00.0% | Unchanged |
| Zimmer Partners, LP | 216,138 | $566.3K | 0.01% | +37,112+20.7% | Added |
| Eventide Asset Management, LLC | 458,317 | $1.20M | 0.02% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 464,821 | $1.22M | 0.01% | +95,041+25.7% | Added |
| Sectoral Asset Management Inc | 517,648 | $1.36M | 0.55% | 00.0% | Unchanged |
| 72 Investment Holdings, LLC | 549,980 | $1.44M | 3.62% | −10.0% | Reduced |
| Vanguard Group Inc | 578,995 | $1.52M | 0.00% | +209,319+56.6% | Added |
| Citadel Advisors LLC | 684,633 | $1.79M | 0.00% | −2040.0% | Reduced |
| Takeda Pharmaceutical Co Ltd | 895,824 | $2.35M | 1.01% | 00.0% | Unchanged |
| Bank of America Corp | 910,781 | $2.39M | 0.00% | +11,408+1.3% | Added |
| PFM Health Sciences, LP | 932,348 | $2.44M | 0.13% | +11,372+1.2% | Added |
| Point72 Asset Management, L.P. | 1,118,588 | $2.93M | 0.01% | −65,300−5.5% | Reduced |
| FMR LLC | 1,135,249 | $2.97M | 0.00% | −439,577−27.9% | Reduced |
| OrbiMed Advisors LLC | 3,099,265 | $8.12M | 0.17% | 00.0% | Unchanged |
| State Street Corp | 0 | $0 | 0.00% | −38,491−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −34,443−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,616−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,013−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −1,755−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −796−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −630−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −178−100.0% | Sold out |